Mike Patten

Mike Patten is Chief Strategy Officer at Harbour BioMed, where he is responsible for shaping and executing the company’s global corporate development and growth strategy. He also leads global alliance efforts, strengthening strategic partnerships and expanding the company’s presence across key international markets. Mike brings extensive experience in the biopharmaceutical industry, with a strong track record in business development, venture investment, and alliance management. Prior to joining Harbour BioMed, he held senior leadership roles at Bristol Myers Squibb, most recently as Head of Equity & Venture Capital, where he led strategic investments across the life sciences ecosystem. Earlier in his career, he held roles of increasing responsibility across business development and global alliances, successfully executing transactions and managing partnerships spanning early- and late-stage assets.